Članci na temu Novo Nordisk

Život

Tržišna kapitalizacija proizvođača Ozempica upravo je premašila Teslu

Sada su dvanaesta najvrjednija tvrtka na svijetu
Piše Eva Benedik 08. 03. 2024.
LOS ANGELES, CALIFORNIA - APRIL 17: In this photo illustration, boxes of the diabetes drug Ozempic rest on a pharmacy counter on April 17, 2023 in Los Angeles, California. Ozempic was originally approved by the FDA to treat people with Type 2 diabetes- who risk serious health consequences without medication. In recent months, there has been a spike in demand for Ozempic, or semaglutide, due to its weight loss benefits, which has led to shortages. Some doctors prescribe Ozempic off-label to treat obesity. (Photo illustration by Mario Tama/Getty Images) (Photo by MARIO TAMA / GETTY IMAGES NORTH AMERICA / Getty Images via AFP)
Biznis & tech
I male promjene u ponašanju potrošača mogu imati velike financijske implikacije
Piše Katarina Škaro 73 preporuka 08. 02. 2024.
Biznis & tech
Novo Nordisk svoj nevjerojatan uspon zahvaljuje lijekovima Wegovy i Ozempic
Piše Mladen Pleše 223 preporuka 05. 01. 2024.
Vijesti
Dionice danske farmaceutske kompanije Novo Nordisk porasle su za 3 posto
Piše Katarina Škaro 83 preporuka 15. 11. 2023.
Posebne pogodnosti

Specijalni newsletteri za Telegramove pretplatnike.

Najbolje od Telegrama, svaki dan u vašem inboxu.
Kolekcija Telegramovih newslettera
Prijavite se
Odaberite tematske i autorske newslettere koje želite primati.
LOS ANGELES, CALIFORNIA - APRIL 17: In this photo illustration, boxes of the diabetes drug Ozempic rest on a pharmacy counter on April 17, 2023 in Los Angeles, California. Ozempic was originally approved by the FDA to treat people with Type 2 diabetes- who risk serious health consequences without medication. In recent months, there has been a spike in demand for Ozempic, or semaglutide, due to its weight loss benefits, which has led to shortages. Some doctors prescribe Ozempic off-label to treat obesity. (Photo illustration by Mario Tama/Getty Images) (Photo by MARIO TAMA / GETTY IMAGES NORTH AMERICA / Getty Images via AFP)
Vijesti
Novo Nordisk je objavio da prekida testiranje lijeka jer su analize pokazale da je uspješan
Piše Telegram 11. 10. 2023.
Biznis & tech

Proizvođač Ozempica postao najvrjednija tvrtka u Europi, s trona skinuo Louis Vuitton

Industrija lijekova za mršavljenje doživljava pravu renesansu
Piše Karlo Došen 201 preporuka 05. 09. 2023.
Život

Počeo veliki lov na sveti gral farmacije. Kinezi lansiraju 'magične' lijekove za mršavljenje, žele izgurati Ozempic

Lijekovi kineskih tvrtki mogli bi postati jeftina alternativa zapadnim lijekovima
Piše Telegram 18 preporuka 17. 08. 2023.
Diabetic disease infographic elements.Diabetes equipment icons set.Flat vector design illustration isolated on white background.Health care concept for banner web flyer brochure., Image: 291988132, License: Royalty-free, Restrictions: , Model Release: no, Credit line: Profimedia, Stock Budget
Politika & Kriminal

Kako se mega farmaceutska tvrtka, zbog inzulina kojem je nabila sumanutu cijenu, našla pred krahom

Novo Nordisk napravio je napredan lijek, ali ljudi ga nisu htjeli kupovati
Piše Mladen Pleše 50 preporuka 30. 08. 2017.